Reinforced Genetic Algorithm for Structure-based Drug Design

• URL: http://arxiv.org/abs/2211.16508v1
• Date: Mon, 28 Nov 2022 22:59:46 GMT
• Title: Reinforced Genetic Algorithm for Structure-based Drug Design
• Authors: Tianfan Fu, Wenhao Gao, Connor W. Coley, Jimeng Sun
• Abstract summary: Structure-based drug design (SBDD) aims to discover drug candidates by finding molecules that bind to a disease-related protein (targets) We propose Reinforced Genetic Algorithm (RGA) that uses neural models to prioritize the profitable design steps and suppress random-walk behavior.
• Score: 38.134929249388406
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Structure-based drug design (SBDD) aims to discover drug candidates by finding molecules (ligands) that bind tightly to a disease-related protein (targets), which is the primary approach to computer-aided drug discovery. Recently, applying deep generative models for three-dimensional (3D) molecular design conditioned on protein pockets to solve SBDD has attracted much attention, but their formulation as probabilistic modeling often leads to unsatisfactory optimization performance. On the other hand, traditional combinatorial optimization methods such as genetic algorithms (GA) have demonstrated state-of-the-art performance in various molecular optimization tasks. However, they do not utilize protein target structure to inform design steps but rely on a random-walk-like exploration, which leads to unstable performance and no knowledge transfer between different tasks despite the similar binding physics. To achieve a more stable and efficient SBDD, we propose Reinforced Genetic Algorithm (RGA) that uses neural models to prioritize the profitable design steps and suppress random-walk behavior. The neural models take the 3D structure of the targets and ligands as inputs and are pre-trained using native complex structures to utilize the knowledge of the shared binding physics from different targets and then fine-tuned during optimization. We conduct thorough empirical studies on optimizing binding affinity to various disease targets and show that RGA outperforms the baselines in terms of docking scores and is more robust to random initializations. The ablation study also indicates that the training on different targets helps improve performance by leveraging the shared underlying physics of the binding processes. The code is available at https://github.com/futianfan/reinforced-genetic-algorithm.

Related papers

• Quantum-inspired Reinforcement Learning for Synthesizable Drug Design [20.00111975801053]
  We introduce a novel approach using the reinforcement learning method with quantum-inspired simulated annealing policy neural network to navigate the vast discrete space of chemical structures intelligently. Specifically, we employ a deterministic REINFORCE algorithm using policy neural networks to output transitional probability to guide state transitions and local search. Our methods are evaluated with the Practical Molecular Optimization (PMO) benchmark framework with a 10K query budget.
  arXiv  Detail & Related papers  (2024-09-13T20:43:16Z)
• Benchmark on Drug Target Interaction Modeling from a Structure Perspective [48.60648369785105]
  Drug-target interaction prediction is crucial to drug discovery and design. Recent methods, such as those based on graph neural networks (GNNs) and Transformers, demonstrate exceptional performance across various datasets. We conduct a comprehensive survey and benchmark for drug-target interaction modeling from a structure perspective, via integrating tens of explicit (i.e., GNN-based) and implicit (i.e., Transformer-based) structure learning algorithms.
  arXiv  Detail & Related papers  (2024-07-04T16:56:59Z)
• Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate? [26.854392279443086]
  Cross-algorithm comparisons in structure-based drug design are scarce. We show that 1D/2D methods achieve competitive performance compared with 3D-based methods that use the 3D structure of the target protein explicitly.
  arXiv  Detail & Related papers  (2024-06-04T15:37:14Z)
• DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization [49.85944390503957]
  DecompOpt is a structure-based molecular optimization method based on a controllable and diffusion model. We show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines.
  arXiv  Detail & Related papers  (2024-03-07T02:53:40Z)
• Protein Design with Guided Discrete Diffusion [67.06148688398677]
  A popular approach to protein design is to combine a generative model with a discriminative model for conditional sampling. We propose diffusioN Optimized Sampling (NOS), a guidance method for discrete diffusion models. NOS makes it possible to perform design directly in sequence space, circumventing significant limitations of structure-based methods.
  arXiv  Detail & Related papers  (2023-05-31T16:31:24Z)
• Structure-based Drug Design with Equivariant Diffusion Models [40.73626627266543]
  We present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel conditioned on protein pockets. Our in silico experiments demonstrate that DiffSBDD captures the statistics of the ground truth data effectively. These results support the assumption that diffusion models represent the complex distribution of structural data more accurately than previous methods.
  arXiv  Detail & Related papers  (2022-10-24T15:51:21Z)
• De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning [8.210294479991118]
  Current approaches to develop molecules for a target protein are intuition-driven, hampered by slow iterative design-test cycles. We propose a novel framework, called 3D-MolGNN$_RL$, coupling reinforcement learning to a deep generative model based on 3D-Scaffold. Our approach can serve as an interpretable artificial intelligence (AI) tool for lead optimization with optimized activity, potency, and biophysical properties.
  arXiv  Detail & Related papers  (2022-05-21T00:47:35Z)
• Improving RNA Secondary Structure Design using Deep Reinforcement Learning [69.63971634605797]
  We propose a new benchmark of applying reinforcement learning to RNA sequence design, in which the objective function is defined to be the free energy in the sequence's secondary structure. We show results of the ablation analysis that we do for these algorithms, as well as graphs indicating the algorithm's performance across batches.
  arXiv  Detail & Related papers  (2021-11-05T02:54:06Z)
• Conservative Objective Models for Effective Offline Model-Based Optimization [78.19085445065845]
  Computational design problems arise in a number of settings, from synthetic biology to computer architectures. We propose a method that learns a model of the objective function that lower bounds the actual value of the ground-truth objective on out-of-distribution inputs. COMs are simple to implement and outperform a number of existing methods on a wide range of MBO problems.
  arXiv  Detail & Related papers  (2021-07-14T17:55:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.